Blue Jet Healthcare quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	293	355	−17.4%
EBITDA	98.1	121	−18.9%
EBITDA margin	33.5%	34.1%	−0.6 pts
Profit before tax	106	123	−13.8%
Net profit	78.3	91.2	−14.2%
EPS	₹4.51	₹5.26	−14.3%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023

Expenses
	293	235	192	165	355	340	318	208	163	184	167	181
	15.2	22.9	13.2	24.3	8.3	12.2	13.2	12.1	8.7	8.8	6.8	8.2
	308	258	206	190	363	353	332	220	172	193	174	190
	179	92.9	78.9	108	108	163	171	115	90.9	58.6	67.2	95.0
	−41.8	9.3	13.9	−50.6	75.0	−10.0	−26.8	−25.1	−17.1	27.4	3.7	−16.7
	20.1	18.5	19.1	18.6	17.4	16.0	14.8	15.4	14.8	14.1	13.0	13.3
	0.7	0.6	0.3	4.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	6.7	6.5	6.0	5.9	5.7	4.9	4.7	4.6	3.5	7.7	7.9	6.5
	37.8	42.7	33.6	34.1	33.4	31.0	35.1	33.9	30.0	30.8	28.3	27.1
	202	170	152	121	240	205	199	143	122	139	120	125
	98.1	71.3	46.9	54.9	121	140	124	69.5	44.3	53.1	54.6	62.6
	91.4	64.8	40.9	49.1	115	135	119	64.9	40.8	45.4	46.7	56.2
Profit
	106	87.1	53.8	68.7	123	147	132	76.9	49.5	54.2	53.4	64.3
	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−9.7	0.0
	106	87.1	53.8	68.7	123	147	132	76.9	49.5	54.2	43.7	64.3
	26.5	21.6	12.0	17.9	29.8	36.8	32.5	17.8	9.8	11.8	12.6	15.5
	1.2	1.2	1.6	−1.3	1.9	0.3	1.0	0.8	1.9	2.7	−1.0	1.0
	27.7	22.8	13.6	16.6	31.7	37.1	33.5	18.6	11.7	14.5	11.6	16.5
	78.3	64.3	40.2	52.1	91.2	110	99.0	58.3	37.8	39.5	32.1	47.9
	78.3	64.3	40.2	52.1	91.2	110	99.0	58.3	37.8	39.7	32.1	47.9
	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−0.2	0.0	0.0
	0.0	0.1	−0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
	78.3	64.4	39.8	52.2	91.2	110	99.0	58.3	37.8	39.5	32.1	47.9
Per share
	₹4.51	₹3.71	₹2.32	₹3.01	₹5.26	₹6.35	₹5.71	₹3.36	₹2.18	₹2.29	₹1.85	₹2.76
	₹4.51	₹3.71	₹2.32	₹3.01	₹5.26	₹6.35	₹5.71	₹3.36	₹2.18	₹2.29	₹1.85	₹2.76
Continuing & discontinued operations
	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−0.2	0.0	0.0
	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−0.1	0.0	0.0
Other comprehensive income — detail
	0.0	0.1	−0.4	0.1	0.0	0.0	—	—	—	—	—	—
	—	0.1	−0.5	0.1	—	0.0	—	—	—	—	0.0	0.1
	0.0	0.0	−0.1	0.0	0.0	0.0	—	—	—	—	—	—
	—	—	—	—	—	—	0.0	0.0	0.0	0.0	0.0	0.0
Per share — as-filed variants
	₹4.51	₹3.71	₹2.32	₹3.01	₹5.26	₹6.35	₹5.71	₹3.36	₹2.18	₹2.29	₹1.85	₹2.76
	₹4.51	₹3.71	₹2.32	₹3.01	₹5.26	₹6.35	₹5.71	₹3.36	₹2.18	₹2.29	₹1.85	₹2.76
Regulatory disclosures — filed alongside, not part of the P&L
	—	9.9	—	10.2	—	12.3	—	—	—	—	—	—
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	156	132	99.6	108	172	187	174	119	89.1	98.0	95.9	103
	53.2%	56.4%	51.7%	65.0%	48.4%	54.9%	54.6%	57.0%	54.7%	53.3%	57.5%	56.8%
Adjusted (ex-exceptional items) — derived
	106	87.1	53.8	68.7	123	147	132	76.9	49.5	54.2	53.4	64.3
	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−9.7	0.0
	78.3	64.3	40.2	52.1	91.2	110	99.0	58.3	37.8	39.5	39.3	47.9
	₹4.51	₹3.71	₹2.32	₹3.01	₹5.26	₹6.35	₹5.71	₹3.36	₹2.18	₹2.29	₹2.26	₹2.76

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

BLUEJET₹517.85

Blue Jet Healthcare Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersDIVISLAB AARTIPHARM CAPLIPOINT ACUTAAS CONCORDBIO EMCURE ERIS GRANULES

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	181.4	166.8	183.9	162.9	208.3	318.4	340.4	354.8	165.5	192.4	234.7	293.1
Other Income	8.2	6.8	8.8	8.7	12.1	13.2	12.2	8.3	24.3	13.2	22.9	15.2
Total Income	189.6	173.5	192.8	171.6	220.3	331.6	352.7	363.0	189.8	205.6	257.6	308.4
Expenses
+ Cost of Materials Consumed	95.0	67.2	58.6	90.9	114.6	171.2	163.5	107.9	108.4	78.9	92.9	178.9
+ Changes in Inventories	-16.7	3.7	27.4	-17.1	-25.1	-26.8	-10.0	75.0	-50.6	13.9	9.3	-41.8
+ Employee Benefit Expense	13.3	13.0	14.1	14.8	15.4	14.8	16.0	17.4	18.6	19.1	18.5	20.1
+ Finance Costs	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.6	0.3	0.6	0.7
+ Depreciation & Amortisation	6.5	7.9	7.7	3.5	4.6	4.7	4.9	5.7	5.9	6.0	6.5	6.7
+ Other Expenses	27.1	28.3	30.8	30.0	33.9	35.1	31.0	33.4	34.1	33.6	42.7	37.8
Total Expenses	125.2	120.1	138.6	122.1	143.4	199.1	205.5	240.2	121.0	151.8	170.4	202.4
EBITDA	62.6	54.6	53.1	44.3	69.5	124.0	140.0	121.0	54.9	46.9	71.3	98.1
EBIT	56.2	46.7	45.4	40.8	64.9	119.3	135.0	115.3	49.1	40.9	64.8	91.4
Profit
PBT before Exceptional Items	64.3	53.4	54.2	49.5	76.9	132.5	147.2	122.9	68.7	53.8	87.1	105.9
+ Exceptional Items	0.0	-9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Pretax Income	64.3	43.7	54.2	49.5	76.9	132.5	147.2	122.9	68.7	53.8	87.1	105.9
+ Current Tax	15.5	12.6	11.8	9.8	17.8	32.5	36.8	29.8	17.9	12.0	21.6	26.5
+ Deferred Tax	1.0	-1.0	2.7	1.9	0.8	1.0	0.3	1.9	-1.3	1.6	1.2	1.2
Tax Expense	16.5	11.6	14.5	11.7	18.6	33.5	37.1	31.7	16.6	13.6	22.8	27.7
Net Income	47.9	32.1	39.5	37.8	58.3	99.0	110.1	91.2	52.1	40.2	64.3	78.3
+ Net Income — Continuing Ops	47.9	32.1	39.7	37.8	58.3	99.0	110.1	91.2	52.1	40.2	64.3	78.3
+ Net Income — Discontinued Ops	0.0	0.0	-0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
+ Other Comprehensive Income	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	-0.4	0.1	0.0
Total Comprehensive Income	47.9	32.1	39.5	37.8	58.3	99.0	110.1	91.2	52.2	39.8	64.4	78.3
Per Share
Basic EPS	2.76	1.85	2.29	2.18	3.36	5.71	6.35	5.26	3.01	2.32	3.71	4.51
Diluted EPS	2.76	1.85	2.29	2.18	3.36	5.71	6.35	5.26	3.01	2.32	3.71	4.51
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax	0.0	0.0	-0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
+ Tax — Discontinued Operations	0.0	0.0	-0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	0.0	0.0	0.1	-0.4	0.1	0.0
+ Items NOT to be Reclassified to P&L	0.1	0.0	—	—	—	—	0.0	—	0.1	-0.5	0.1	—
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	0.0	0.0	0.0	-0.1	0.0	0.0
+ Tax on Items NOT to be Reclassified — alt tag	0.0	0.0	0.0	0.0	0.0	0.0	—	—	—	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	2.76	1.85	2.29	2.18	3.36	5.71	6.35	5.26	3.01	2.32	3.71	4.51
Diluted EPS — Continuing Operations	2.76	1.85	2.29	2.18	3.36	5.71	6.35	5.26	3.01	2.32	3.71	4.51
Regulatory Disclosures — filed alongside, not part of the P&L
Related-party Transactions — During the Period	—	—	—	—	—	—	12.3	—	10.2	—	9.9	—
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	103.0	95.9	98.0	89.1	118.7	174.0	187.0	171.9	107.6	99.6	132.5	156.0
Gross Margin %	56.81	57.51	53.26	54.69	57.02	54.64	54.92	48.44	65.03	51.75	56.45	53.22
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	64.3	53.4	54.2	49.5	76.9	132.5	147.2	122.9	68.7	53.8	87.1	105.9
− Exceptional Items (reconciliation)	0.0	-9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net Income Adj (tax-effected)	47.9	39.3	39.5	37.8	58.3	99.0	110.1	91.2	52.1	40.2	64.3	78.3
EPS Adj	2.76	2.26	2.29	2.18	3.36	5.71	6.35	5.26	3.01	2.32	3.71	4.51
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00
Filed Dscr	71.00	0.00	0.00	0.00	—	—	—	—	—	—	—	—
Paid Up Equity Capital	34.7	34.7	34.7	34.7	34.7	34.7	34.7	34.7	34.7	34.7	34.7	34.7

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Blue Jet Healthcare Q2 FY27 results date

Blue Jet Healthcare (NSE: BLUEJET) will announce its Q2 FY27 results (July–September 2026) on Thursday, 5 November 2026, according to the board-meeting notice it filed on 29 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹78.3 crore, down 14.2% from ₹91.2 crore in Q1 FY26 and up 21.6% from ₹64.3 crore in Q4 FY26. Revenue from operations was ₹293 crore, down 17.4% year on year and up 24.9% from the previous quarter.

Board-meeting notice filed: 29 October 2026
Q2 FY26 results (a year earlier): 4 November 2025
Q1 FY27 results (the latest): 3 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date: 5 November 2026Thursday · notice filed 29 Oct
Q1 FY27 net profit: ₹78.3 Cr−14.2% vs Q1 FY26+21.6% vs Q4 FY26
Q1 FY27 revenue: ₹293 Cr−17.4% vs Q1 FY26+24.9% vs Q4 FY26
Q1 FY27 operating margin: 31.2%−1.3 pts vs Q1 FY26+3.6 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹52.1 CrRevenue ₹165 Cr
Q1 FY27 EPS (basic): ₹4.51

Questions

When will Blue Jet Healthcare announce its Q2 FY27 results?

On 5 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 29 October 2026). Last year it reported Q2 FY26 on 4 November 2025.

What will Blue Jet Healthcare's Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹52.1 crore and revenue from operations ₹165 crore. The latest quarter, Q1 FY27, had a net profit of ₹78.3 crore and revenue of ₹293 crore.

What were Blue Jet Healthcare's Q1 FY27 results?

Consolidated net profit was ₹78.3 crore, down 14.2% from ₹91.2 crore in Q1 FY26 and up 21.6% from ₹64.3 crore in Q4 FY26. Revenue from operations was ₹293 crore, down 17.4% year on year and up 24.9% from the previous quarter.

How has Blue Jet Healthcare's profit changed over the last four quarters?

Net profit by quarter: ₹52.1 crore in Q2 FY26, ₹40.2 crore in Q3 FY26, ₹64.3 crore in Q4 FY26 and ₹78.3 crore in Q1 FY27. That is ₹235 crore over the four quarters, down 34.5% from ₹359 crore in the four quarters before. Revenue from operations: ₹165 crore, ₹192 crore, ₹235 crore and ₹293 crore.

Where do these Blue Jet Healthcare figures come from?

From Blue Jet Healthcare's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.